Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 854 results for "Novartis Company"

Novartis gets EU nod for psoriasis biologic drug
Bio Spectrum Asia

Novartis gets EU nod for psoriasis biologic drug

Singapore: Global pharmaceutical company, Novartis, has recieved European Commission (EC) nod for Cosentyx (secukinumab, formerly known as AIN457) as a first-line systemic treatment of moderate-to-severe plaque psoriasis in adults who are candidates ... Bio Spectrum Asia, 6 days ago
FDA Says Yes To Novartis AG Psoriasis Drug Bidness Etc, 4 days ago
[x]  
EuroInvestor

Novartis Bexsero® vaccine approved by FDA for the prevention of meningitis B, the leading cause of bacterial meningitis in the US - HTML (w)

Company : NOVARTIS Compartment : Other ISIN : CH0012005267 Wire : Thomson Reuters ONE Document type : Permanent Information Releases / General Company News Publication date : 1/23/2015 11:37:00 PM ...
 WorldRegInfo2 days ago EU committee backs expanded approval of Novartis' Jakavi for polycythaemia vera  FirstWord Pharma2 days ago Novartis: CHMP Adopts Positive Opinion For Jakavi - Quick Facts  RTTNews.com2 days ago NOVARTIS : drug Jakavi® recommended by CHMP for EU approval to treat adults with rare blood cancer polycythemia vera  4 Traders3 days ago
[x]  

Novartis takes RTI route, blocks local firm's bid to copy anti-diabetes drug

AHMEDABAD:Swiss pharmaceutical giant Novartis has restrained a local pharma company from making anti-diabetes drug by approaching a court because the MNC had patented the drug and is enjoying monopoly over its production and sale. Interestingly, ...
 Times of India1 week ago NOVARTIS : takes RTI route, blocks local firm's bid to copy anti-diabetes drug  4 Traders6 days ago
Business Standard

Life and lung issue in Cipla-Novartis battle

e with respiratory ailments have a big personal stake in the legal wrangle between drug companies Cipla and Novartis over Onbrez, the drug used to treat the condition. According to the World Health Organisation, India has an estimated 10.2 million persons ...
 Business Standard1 week ago Government may not act on Cipla’s patent plea  Times of India1 month ago Cipla's audacious move  Down to Earth2 months ago Cipla-Novartis patent row: DIPP looking into merit of case  The Financial Chronicle2 months ago

Novartis India slips as board approves transfer of OTC business

Novartis India fell 1.4% to Rs 663 at 11:36 IST on BSE after the company's board of directors approved the transfer of its OTC division to GlaxoSmithKline Consumer as part of its global portfolio transformation. Meanwhile, the BSE Sensex was down 56.40 ...
 Business Standard1 week ago Novartis India: Outcome of board meeting  Money Control2 months ago
BizWest

Array to Acquire Rights to Novartis Cancer Drug

- US-based biopharmaceutical company Array BioPharma Inc According to the parties, this agreementis conditional on the closing of transactions announced by Novartis and GlaxoSmithKline PLC onApril 22, 2014, which are expected to close in the first ...
 BusinessWeek2 days ago Array BioPharma (ARRY) To Acquire Global Rights For Novartis (NVS) Cancer Drug  Bidness Etc1 day ago Boulder biopharma luring array of investment  BizWest2 days ago

Novartis buys 12.8% stake in BioLineRX

Swiss drugmaker Novartis AG bought a 12.8 per cent stake in Israeli biopharmaceutical company BioLineRX Ltd as part of a multi-year collaboration deal, BioLineRX said on Tuesday.Under the agreement, Novartis, which invested an initial $10 million, ...
 Business Standard1 month ago Novartis buys 12.8 per cent stake in BioLineRX in co-development deal  Economic Times1 month ago

U.S. approves GSK's purchase of Novartis vaccine business: companies

WASHINGTON (Reuters) - GlaxoSmithKline won U.S. antitrust approval to buy Novartis AG's vaccine business, with the exception of influenza vaccines, the two companies said on Wednesday. The deal is part of a three-way transaction unveiled in April, which ...
 Reuters2 months ago US approves GSK's purchase of Novartis vaccine business  Economic Times1 month ago

Novartis and Qualcomm Form Digital Health Investment Company

Novartis Pharmaceuticals has announced it has formed a joint investment company with Qualcomm Ventures, the venture investment group of Qualcomm. The company — dRx Capital AG — will invest up to $100 million to support early stage digital ...
 JD Supra2 days ago Qualcomm and Novartis partner to improve wearable health technology  Irish Computer Society3 days ago Qualcomm and Novartis to invest up to $100M in health technology companies  Clinical Innovation & Technology4 days ago Novartis Pharmaceuticals announces a joint investment company with Qualcomm, leading innovation in digital medicines for physicians and patients  Fierce Biotech IT6 days ago

Novartis scores the first victory in a blockbuster psoriasis race

Novartis ($NVS) picked up European approval to sell its secukinumab as a treatment for psoriasis, step one in the company's plot to build a global anti-inflammatory contender and outpace its rivals. The injected treatment, to be marketed as ...
 FierceBiotech4 days ago UPDATED: Novartis scores the first victory in a blockbuster psoriasis race  FierceBiotech4 days ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less